How long should we follow patients after apparently curative parathyroidectomy?

Background Little is known about the long-term recurrence risk for primary hyperparathyroidism after immediately “curative” parathyroidectomy. This study aimed to evaluate the risk of recurrent hyperparathyroidism in the 10 years after operation. Method We retrospectively identified patients with sp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgery 2017-01, Vol.161 (1), p.54-61
Hauptverfasser: Lou, Irene, MD, Balentine, Courtney, MD, MPH, Clarkson, Samuel, BA, Schneider, David F., MD, MS, Sippel, Rebecca S., MD, Chen, Herbert, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 61
container_issue 1
container_start_page 54
container_title Surgery
container_volume 161
creator Lou, Irene, MD
Balentine, Courtney, MD, MPH
Clarkson, Samuel, BA
Schneider, David F., MD, MS
Sippel, Rebecca S., MD
Chen, Herbert, MD
description Background Little is known about the long-term recurrence risk for primary hyperparathyroidism after immediately “curative” parathyroidectomy. This study aimed to evaluate the risk of recurrent hyperparathyroidism in the 10 years after operation. Method We retrospectively identified patients with sporadic primary hyperparathyroidism undergoing initial parathyroidectomy between November 1, 2000 and June 30, 2005. Recurrence was defined as serum calcium >10.2 mg/dL after 6 months from operation. Kaplan-Meier estimates and Cox proportional hazards were used to evaluate disease-free survival and predictors of recurrence. Results We evaluated 196 patients with a 14.8% 10-year recurrence rate. Median time to recurrence was 6.3 years (interquartile range 3.4–10.8 years), and 34.5% of all recurrences were identified >10 years after operation. There was no difference in recurrence between open and minimally invasive operation ( P  = .448). Double adenomas ( P  = .006), intraoperative parathyroid hormone drop 10 years after the initial operation, long-term follow-up is essential.
doi_str_mv 10.1016/j.surg.2016.05.049
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5164956</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0039606016304962</els_id><sourcerecordid>1841792480</sourcerecordid><originalsourceid>FETCH-LOGICAL-c510t-def4bcd006ef4b3edaf2a8e763079a38840bd214d46e6a91937b838a868bd7f13</originalsourceid><addsrcrecordid>eNp9UsFu1DAUtBCIbgs_wAHlyCXBjh3HllBRVUGLVKkH4Gw59suuF28c7GSr_D2OtlTAgZPHfvPGTzMPoTcEVwQT_n5fpTluqzrjCjcVZvIZ2pCG1mVLOXmONhhTWXLM8Rk6T2mPMZaMiJforG4Fp20rN-j-NjwUPgzbIu3C7G3xAEUfvM-vo54cDFMqdD9BLPQ46pjvfinMHHPtCJmSwW6JwVkwUzgsH1-hF732CV4_nhfo--dP365vy7v7my_XV3elaQieSgs964zFmK-AgtV9rQW0nOJWaioEw52tCbOMA9eSSNp2ggotuOhs2xN6gS5PuuPcHcCaPFjUXo3RHXRcVNBO_V0Z3E5tw1E1hDPZ8Czw7lEghp8zpEkdXDLgvR4gzEkRwUgrayZwptYnqokhpQj90zcEqzUJtVdrEmpNQuFG5SRy09s_B3xq-W19Jnw4ESDbdHQQVTLZbwPWxWymssH9X__yn3bj3eCM9j9ggbQPcxxyAIqoVCusvq67sK4CyRYzyWv6C9HKsh0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1841792480</pqid></control><display><type>article</type><title>How long should we follow patients after apparently curative parathyroidectomy?</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Lou, Irene, MD ; Balentine, Courtney, MD, MPH ; Clarkson, Samuel, BA ; Schneider, David F., MD, MS ; Sippel, Rebecca S., MD ; Chen, Herbert, MD</creator><creatorcontrib>Lou, Irene, MD ; Balentine, Courtney, MD, MPH ; Clarkson, Samuel, BA ; Schneider, David F., MD, MS ; Sippel, Rebecca S., MD ; Chen, Herbert, MD</creatorcontrib><description>Background Little is known about the long-term recurrence risk for primary hyperparathyroidism after immediately “curative” parathyroidectomy. This study aimed to evaluate the risk of recurrent hyperparathyroidism in the 10 years after operation. Method We retrospectively identified patients with sporadic primary hyperparathyroidism undergoing initial parathyroidectomy between November 1, 2000 and June 30, 2005. Recurrence was defined as serum calcium &gt;10.2 mg/dL after 6 months from operation. Kaplan-Meier estimates and Cox proportional hazards were used to evaluate disease-free survival and predictors of recurrence. Results We evaluated 196 patients with a 14.8% 10-year recurrence rate. Median time to recurrence was 6.3 years (interquartile range 3.4–10.8 years), and 34.5% of all recurrences were identified &gt;10 years after operation. There was no difference in recurrence between open and minimally invasive operation ( P  = .448). Double adenomas ( P  = .006), intraoperative parathyroid hormone drop &lt;70% ( P  = .015), and young age ( P  = .032) were predictive of disease recurrence. Multivariable analysis demonstrated that older age was protective against recurrence (hazard ratio 0.97, 95% confidence interval 0.94–0.99, P  = .034), while double adenomas (hazard ratio 3.52, 95% confidence interval 1.23–10.08, P  = .019) were an independent predictor for recurrence. Conclusion The long-term recurrence rate for sporadic primary hyperparathyroidism after “curative” parathyroidectomy is likely greater than reported. With over one-third of our institutional recurrences at &gt;10 years after the initial operation, long-term follow-up is essential.</description><identifier>ISSN: 0039-6060</identifier><identifier>EISSN: 1532-7361</identifier><identifier>DOI: 10.1016/j.surg.2016.05.049</identifier><identifier>PMID: 27863779</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Age Factors ; Aged ; Analysis of Variance ; Cohort Studies ; Databases, Factual ; Female ; Follow-Up Studies ; Humans ; Hyperparathyroidism, Primary - diagnosis ; Hyperparathyroidism, Primary - surgery ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multivariate Analysis ; Parathyroid Hormone - blood ; Parathyroidectomy - adverse effects ; Parathyroidectomy - methods ; Proportional Hazards Models ; Recurrence ; Retrospective Studies ; Risk Assessment ; Severity of Illness Index ; Sex Factors ; Surgery ; Time Factors</subject><ispartof>Surgery, 2017-01, Vol.161 (1), p.54-61</ispartof><rights>Elsevier Inc.</rights><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c510t-def4bcd006ef4b3edaf2a8e763079a38840bd214d46e6a91937b838a868bd7f13</citedby><cites>FETCH-LOGICAL-c510t-def4bcd006ef4b3edaf2a8e763079a38840bd214d46e6a91937b838a868bd7f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.surg.2016.05.049$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27863779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lou, Irene, MD</creatorcontrib><creatorcontrib>Balentine, Courtney, MD, MPH</creatorcontrib><creatorcontrib>Clarkson, Samuel, BA</creatorcontrib><creatorcontrib>Schneider, David F., MD, MS</creatorcontrib><creatorcontrib>Sippel, Rebecca S., MD</creatorcontrib><creatorcontrib>Chen, Herbert, MD</creatorcontrib><title>How long should we follow patients after apparently curative parathyroidectomy?</title><title>Surgery</title><addtitle>Surgery</addtitle><description>Background Little is known about the long-term recurrence risk for primary hyperparathyroidism after immediately “curative” parathyroidectomy. This study aimed to evaluate the risk of recurrent hyperparathyroidism in the 10 years after operation. Method We retrospectively identified patients with sporadic primary hyperparathyroidism undergoing initial parathyroidectomy between November 1, 2000 and June 30, 2005. Recurrence was defined as serum calcium &gt;10.2 mg/dL after 6 months from operation. Kaplan-Meier estimates and Cox proportional hazards were used to evaluate disease-free survival and predictors of recurrence. Results We evaluated 196 patients with a 14.8% 10-year recurrence rate. Median time to recurrence was 6.3 years (interquartile range 3.4–10.8 years), and 34.5% of all recurrences were identified &gt;10 years after operation. There was no difference in recurrence between open and minimally invasive operation ( P  = .448). Double adenomas ( P  = .006), intraoperative parathyroid hormone drop &lt;70% ( P  = .015), and young age ( P  = .032) were predictive of disease recurrence. Multivariable analysis demonstrated that older age was protective against recurrence (hazard ratio 0.97, 95% confidence interval 0.94–0.99, P  = .034), while double adenomas (hazard ratio 3.52, 95% confidence interval 1.23–10.08, P  = .019) were an independent predictor for recurrence. Conclusion The long-term recurrence rate for sporadic primary hyperparathyroidism after “curative” parathyroidectomy is likely greater than reported. With over one-third of our institutional recurrences at &gt;10 years after the initial operation, long-term follow-up is essential.</description><subject>Age Factors</subject><subject>Aged</subject><subject>Analysis of Variance</subject><subject>Cohort Studies</subject><subject>Databases, Factual</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hyperparathyroidism, Primary - diagnosis</subject><subject>Hyperparathyroidism, Primary - surgery</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Parathyroid Hormone - blood</subject><subject>Parathyroidectomy - adverse effects</subject><subject>Parathyroidectomy - methods</subject><subject>Proportional Hazards Models</subject><subject>Recurrence</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Severity of Illness Index</subject><subject>Sex Factors</subject><subject>Surgery</subject><subject>Time Factors</subject><issn>0039-6060</issn><issn>1532-7361</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UsFu1DAUtBCIbgs_wAHlyCXBjh3HllBRVUGLVKkH4Gw59suuF28c7GSr_D2OtlTAgZPHfvPGTzMPoTcEVwQT_n5fpTluqzrjCjcVZvIZ2pCG1mVLOXmONhhTWXLM8Rk6T2mPMZaMiJforG4Fp20rN-j-NjwUPgzbIu3C7G3xAEUfvM-vo54cDFMqdD9BLPQ46pjvfinMHHPtCJmSwW6JwVkwUzgsH1-hF732CV4_nhfo--dP365vy7v7my_XV3elaQieSgs964zFmK-AgtV9rQW0nOJWaioEw52tCbOMA9eSSNp2ggotuOhs2xN6gS5PuuPcHcCaPFjUXo3RHXRcVNBO_V0Z3E5tw1E1hDPZ8Czw7lEghp8zpEkdXDLgvR4gzEkRwUgrayZwptYnqokhpQj90zcEqzUJtVdrEmpNQuFG5SRy09s_B3xq-W19Jnw4ESDbdHQQVTLZbwPWxWymssH9X__yn3bj3eCM9j9ggbQPcxxyAIqoVCusvq67sK4CyRYzyWv6C9HKsh0</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Lou, Irene, MD</creator><creator>Balentine, Courtney, MD, MPH</creator><creator>Clarkson, Samuel, BA</creator><creator>Schneider, David F., MD, MS</creator><creator>Sippel, Rebecca S., MD</creator><creator>Chen, Herbert, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170101</creationdate><title>How long should we follow patients after apparently curative parathyroidectomy?</title><author>Lou, Irene, MD ; Balentine, Courtney, MD, MPH ; Clarkson, Samuel, BA ; Schneider, David F., MD, MS ; Sippel, Rebecca S., MD ; Chen, Herbert, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c510t-def4bcd006ef4b3edaf2a8e763079a38840bd214d46e6a91937b838a868bd7f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Age Factors</topic><topic>Aged</topic><topic>Analysis of Variance</topic><topic>Cohort Studies</topic><topic>Databases, Factual</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hyperparathyroidism, Primary - diagnosis</topic><topic>Hyperparathyroidism, Primary - surgery</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Parathyroid Hormone - blood</topic><topic>Parathyroidectomy - adverse effects</topic><topic>Parathyroidectomy - methods</topic><topic>Proportional Hazards Models</topic><topic>Recurrence</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Severity of Illness Index</topic><topic>Sex Factors</topic><topic>Surgery</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lou, Irene, MD</creatorcontrib><creatorcontrib>Balentine, Courtney, MD, MPH</creatorcontrib><creatorcontrib>Clarkson, Samuel, BA</creatorcontrib><creatorcontrib>Schneider, David F., MD, MS</creatorcontrib><creatorcontrib>Sippel, Rebecca S., MD</creatorcontrib><creatorcontrib>Chen, Herbert, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lou, Irene, MD</au><au>Balentine, Courtney, MD, MPH</au><au>Clarkson, Samuel, BA</au><au>Schneider, David F., MD, MS</au><au>Sippel, Rebecca S., MD</au><au>Chen, Herbert, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>How long should we follow patients after apparently curative parathyroidectomy?</atitle><jtitle>Surgery</jtitle><addtitle>Surgery</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>161</volume><issue>1</issue><spage>54</spage><epage>61</epage><pages>54-61</pages><issn>0039-6060</issn><eissn>1532-7361</eissn><abstract>Background Little is known about the long-term recurrence risk for primary hyperparathyroidism after immediately “curative” parathyroidectomy. This study aimed to evaluate the risk of recurrent hyperparathyroidism in the 10 years after operation. Method We retrospectively identified patients with sporadic primary hyperparathyroidism undergoing initial parathyroidectomy between November 1, 2000 and June 30, 2005. Recurrence was defined as serum calcium &gt;10.2 mg/dL after 6 months from operation. Kaplan-Meier estimates and Cox proportional hazards were used to evaluate disease-free survival and predictors of recurrence. Results We evaluated 196 patients with a 14.8% 10-year recurrence rate. Median time to recurrence was 6.3 years (interquartile range 3.4–10.8 years), and 34.5% of all recurrences were identified &gt;10 years after operation. There was no difference in recurrence between open and minimally invasive operation ( P  = .448). Double adenomas ( P  = .006), intraoperative parathyroid hormone drop &lt;70% ( P  = .015), and young age ( P  = .032) were predictive of disease recurrence. Multivariable analysis demonstrated that older age was protective against recurrence (hazard ratio 0.97, 95% confidence interval 0.94–0.99, P  = .034), while double adenomas (hazard ratio 3.52, 95% confidence interval 1.23–10.08, P  = .019) were an independent predictor for recurrence. Conclusion The long-term recurrence rate for sporadic primary hyperparathyroidism after “curative” parathyroidectomy is likely greater than reported. With over one-third of our institutional recurrences at &gt;10 years after the initial operation, long-term follow-up is essential.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27863779</pmid><doi>10.1016/j.surg.2016.05.049</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0039-6060
ispartof Surgery, 2017-01, Vol.161 (1), p.54-61
issn 0039-6060
1532-7361
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5164956
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Age Factors
Aged
Analysis of Variance
Cohort Studies
Databases, Factual
Female
Follow-Up Studies
Humans
Hyperparathyroidism, Primary - diagnosis
Hyperparathyroidism, Primary - surgery
Kaplan-Meier Estimate
Male
Middle Aged
Multivariate Analysis
Parathyroid Hormone - blood
Parathyroidectomy - adverse effects
Parathyroidectomy - methods
Proportional Hazards Models
Recurrence
Retrospective Studies
Risk Assessment
Severity of Illness Index
Sex Factors
Surgery
Time Factors
title How long should we follow patients after apparently curative parathyroidectomy?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T14%3A35%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=How%20long%20should%20we%20follow%20patients%20after%20apparently%20curative%20parathyroidectomy?&rft.jtitle=Surgery&rft.au=Lou,%20Irene,%20MD&rft.date=2017-01-01&rft.volume=161&rft.issue=1&rft.spage=54&rft.epage=61&rft.pages=54-61&rft.issn=0039-6060&rft.eissn=1532-7361&rft_id=info:doi/10.1016/j.surg.2016.05.049&rft_dat=%3Cproquest_pubme%3E1841792480%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1841792480&rft_id=info:pmid/27863779&rft_els_id=1_s2_0_S0039606016304962&rfr_iscdi=true